UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Online Course
not accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Infectious Colitis

Laia Peries, Xavier Aldeguer Mante

Summary

AI Generated

An online course by Laia Peries and Xavier Aldeguer covers the aetiology, epidemiology, clinical features, diagnostic approach, treatment options, and complications of infectious colitis, a highly prevalent condition caused by intestinal and some sexually transmitted pathogens.

  • Infectious colitis is a highly prevalent condition and a major cause of morbidity worldwide, with clinical management presenting a medical challenge.
  • The course describes the general diagnostic approach to infectious colitis and presents a diagnostic algorithm.
  • Treatment options for infectious colitis are summarized, and the course raises awareness of complications and special situations.
  • The course is suitable for gastroenterologists in training, physicians and surgeons in other disciplines, nurses, biotechnicians, and advanced-years medical students with an interest in gastroenterology.
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Infectious colitis is a highly prevalent condition and a major cause of morbidity worldwide. Clinical management of infectious colitis, which can be caused by various intestinal pathogens and some sexually transmitted pathogens, is a medical challenge.

This online course provides the latest information on all aspects of infectious colitis. Authors Laia Peries and Xavier Aldeguer discuss the aetiology, epidemiology, symptoms and clinical features. They describe the general diagnostic approach to infectious colitis and present a diagnostic algorithm. They also summarize the treatment options and raise awareness of complications and special situations.

Learning objectives

  • To understand how to reach a conclusive diagnosis of GORD
  • To know how to reach a conclusive diagnosis of no GORD
  • To understand how to deal with an inconclusive diagnosis

Target audience

This course is suitable for gastroenterologists in training, but it is also appropriate for physicians and surgeons in other disciplines who have an interest in infectious colitis, as well as nurses, biotechnicians and advanced-years’ medical students who have an interest in gastroenterology. 

Event

Infectious Colitis

Topics

Small Intestine & Nutrition

Accreditation status

not accredited

Duration

1 hour

Published

2021

More Like This:

Intestinal failure and parenteral nutrition

Intestinal failure and parenteral nutrition

Sarah Williams Sarah Williams, Shameer Mehta

Proctology — haemorrhoids and perianal skin conditions

Proctology — haemorrhoids and perianal skin conditions

Nuha Yassin Nuha Yassin, Janindra Warusavitarne, Harald Rosen

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Acute pancreatitis

Acute pancreatitis

Markus M. Lerch Markus M. Lerch, Ali Alexander Aghdassi

Hereditary gastrointestinal polyposis syndromes

Hereditary gastrointestinal polyposis syndromes

Luigi Ricciardiello Luigi Ricciardiello

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

Boglarka Balogh Boglarka Balogh, Nora Sipeki, Peter Antal-Szalmas, Mária Papp, Jonel Trebicka, Tamás Tornai, Zsuzsanna Vitális, István Tornai, Lukacs Barath, Gabor Mehes, Tamas Dinya, Andras Kiss, Andras Budai, Aniko Csillag, David Tornai

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Intestinal failure and parenteral nutrition

Shameer Mehta, Sarah Williams

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Intestinal failure is the rarest organ failure, but its prevalence across Europe is increasing. Patients have complex conditions and requirements, and optimal care involves multiple specialties and disciplines. Home parenteral nutrition — the first-line treatment for chronic intestinal failure — can significantly impact patients’ lives.

This online course provides in-depth coverage of all aspects of intestinal failure and parenteral nutrition. Authors Shameer Mehta and Sarah Williams discuss the aetiology and management of short bowel syndrome, followed by the causes, classification and management of intestinal failure.

Learning objectives

  • Pathophysiology and management of short bowel syndrome 
  • Classifications, causes and management of intestinal failure 
  • Dietetic principles of parenteral nutrition 
  • Central venous access options 
  • Refeeding syndrome 
  • Indications for home parenteral nutrition  
  • Alternative management strategies for intestinal failure

Target audience

This course is suitable for gastroenterologists in training, colorectal surgeons, nutrition nurses, dietitians, intensivists, and other healthcare professionals looking after patients receiving parenteral nutrition.

Reviewed & updated May 2024

Event

Intestinal failure and parenteral nutrition

Topics

Small Intestine & Nutrition

Accreditation status

accredited

Duration

1 hour

Published

2021

More Like This:

Intestinal failure and parenteral nutrition

Intestinal failure and parenteral nutrition

Sarah Williams Sarah Williams, Shameer Mehta

Proctology — haemorrhoids and perianal skin conditions

Proctology — haemorrhoids and perianal skin conditions

Nuha Yassin Nuha Yassin, Janindra Warusavitarne, Harald Rosen

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Acute pancreatitis

Acute pancreatitis

Markus M. Lerch Markus M. Lerch, Ali Alexander Aghdassi

Hereditary gastrointestinal polyposis syndromes

Hereditary gastrointestinal polyposis syndromes

Luigi Ricciardiello Luigi Ricciardiello

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

Boglarka Balogh Boglarka Balogh, Nora Sipeki, Peter Antal-Szalmas, Mária Papp, Jonel Trebicka, Tamás Tornai, Zsuzsanna Vitális, István Tornai, Lukacs Barath, Gabor Mehes, Tamas Dinya, Andras Kiss, Andras Budai, Aniko Csillag, David Tornai

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Proctology — haemorrhoids and perianal skin conditions

Harald Rosen, Janindra Warusavitarne, Nuha Yassin

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Proctologic disorders are a widespread problem—their high incidence means that many different healthcare professionals (e.g. gastroenterologists, surgeons, dermatologists, nurses, young residents, etc.) will be confronted by patients complaining about a proctologic disease.

This course by European Society of Coloproctology (ESCP) experts Harald Rosen, Janindra Warusavitarne and Nuha Yassin provides the most recent state-of-the-art information on the common proctologic disorders of haemorrhoids and perianal skin conditions.

Learning objectives

  • The anatomy and physiology of haemorrhoids, the most common classification system used to identify patients with problems, and therapeutic management (conservative and surgical) 
  • The diagnosis and treatment of the most common dermatologic problems in the skin of the anal and perianal area 

Target audience

This course is suitable for gastroenterologists and surgeons in training, but is also appropriate for other physicians, as well as nurses, biotechnicians and medical students who have an interest in coloproctology.

Reviewed & updated April 2024

Event

Proctology — haemorrhoids and perianal skin conditions

Topics

Surgery

Accreditation status

accredited

Duration

1 hour

Published

2021

More Like This:

Intestinal failure and parenteral nutrition

Intestinal failure and parenteral nutrition

Sarah Williams Sarah Williams, Shameer Mehta

Proctology — haemorrhoids and perianal skin conditions

Proctology — haemorrhoids and perianal skin conditions

Nuha Yassin Nuha Yassin, Janindra Warusavitarne, Harald Rosen

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Acute pancreatitis

Acute pancreatitis

Markus M. Lerch Markus M. Lerch, Ali Alexander Aghdassi

Hereditary gastrointestinal polyposis syndromes

Hereditary gastrointestinal polyposis syndromes

Luigi Ricciardiello Luigi Ricciardiello

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

Boglarka Balogh Boglarka Balogh, Nora Sipeki, Peter Antal-Szalmas, Mária Papp, Jonel Trebicka, Tamás Tornai, Zsuzsanna Vitális, István Tornai, Lukacs Barath, Gabor Mehes, Tamas Dinya, Andras Kiss, Andras Budai, Aniko Csillag, David Tornai

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Management of early-invasive (T1) colorectal cancer

Alexandra Langers, Jurjen J. Boonstra, James Hardwick

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

With the introduction of population-based screening programs in several countries, the proportion of patients diagnosed with early invasive colorectal cancer (T1 CRC) has been vastly increasing. There are several major challenges in clinical management of this patient group, resulting in significant practice variations among physicians.

This online course covers the most relevant aspects of clinical management of T1 CRC patients, and provides an overview of latest insights and current knowledge gaps. To facilitate the learning process, several questions on real-life patient cases have been included in which learners can bring the acquired knowledge directly into practice.

Learning objectives

  • To systematically assess colorectal lesions and identify those suspicious for submucosally invasive (T1) cancer
  • To learn about local resection techniques for T1 colorectal cancer
  • To gain insight into histological assessment of local en bloc resection specimens of T1 colorectal cancer
  • To be aware of considerations from the oncological and patient perspective in therapeutic decision making after local treatment for T1 colorectal cancer

Target audience

This course is suitable for gastroenterologists, surgeons, pathologists, nurses and any other healthcare professionals interested in, or actively involved in clinical management of T1 CRC patients. 

This course was developed by Alexandra M.J. Langers, Jurjen J. Boonstra, James C.H. Hardwick, Richard (H.) Dang et al. in receipt of an Activity Grant from UEG.

Reviewed & updated December 2022

Event

Management of early-invasive (T1) colorectal cancer

Topics

Digestive Oncology

Accreditation status

accredited

Duration

1 hour

Published

2020

More Like This:

Intestinal failure and parenteral nutrition

Intestinal failure and parenteral nutrition

Sarah Williams Sarah Williams, Shameer Mehta

Proctology — haemorrhoids and perianal skin conditions

Proctology — haemorrhoids and perianal skin conditions

Nuha Yassin Nuha Yassin, Janindra Warusavitarne, Harald Rosen

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Acute pancreatitis

Acute pancreatitis

Markus M. Lerch Markus M. Lerch, Ali Alexander Aghdassi

Hereditary gastrointestinal polyposis syndromes

Hereditary gastrointestinal polyposis syndromes

Luigi Ricciardiello Luigi Ricciardiello

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

Boglarka Balogh Boglarka Balogh, Nora Sipeki, Peter Antal-Szalmas, Mária Papp, Jonel Trebicka, Tamás Tornai, Zsuzsanna Vitális, István Tornai, Lukacs Barath, Gabor Mehes, Tamas Dinya, Andras Kiss, Andras Budai, Aniko Csillag, David Tornai

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Acute pancreatitis

Ali Alexander Aghdassi, Markus M. Lerch

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Acute pancreatitis is the most frequent pancreatic disease and the most common reason for emergency room admission for all nonmalignant gastrointestinal diseases. This rapid-onset and painful inflammation of the pancreas is troublesome to manage because it has a diverse and often unpredictable clinical course. Although the inflammation usually subsides, complications can develop, and some patients will progress to chronic pancreatitis.
Learning objectives

  • The aetiology of acute pancreatitis
  • The different classification systems for acute pancreatitis
  • The diagnosis of acute pancreatitis
  • The therapeutic regimes for acute pancreatitis
    Target audience

This course is suitable for gastroenterologists in training, but it is also appropriate for physicians and surgeons in other disciplines, as well as nurses, biotechnicians and advanced-years’ medical students who have an interest in gastroenterology.

Reviewed & updated February 2023

Event

Acute pancreatitis

Topics

Pancreas

Accreditation status

accredited

Duration

1 hour

Published

2020

More Like This:

Intestinal failure and parenteral nutrition

Intestinal failure and parenteral nutrition

Sarah Williams Sarah Williams, Shameer Mehta

Proctology — haemorrhoids and perianal skin conditions

Proctology — haemorrhoids and perianal skin conditions

Nuha Yassin Nuha Yassin, Janindra Warusavitarne, Harald Rosen

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Acute pancreatitis

Acute pancreatitis

Markus M. Lerch Markus M. Lerch, Ali Alexander Aghdassi

Hereditary gastrointestinal polyposis syndromes

Hereditary gastrointestinal polyposis syndromes

Luigi Ricciardiello Luigi Ricciardiello

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

Boglarka Balogh Boglarka Balogh, Nora Sipeki, Peter Antal-Szalmas, Mária Papp, Jonel Trebicka, Tamás Tornai, Zsuzsanna Vitális, István Tornai, Lukacs Barath, Gabor Mehes, Tamas Dinya, Andras Kiss, Andras Budai, Aniko Csillag, David Tornai

UEG Online Course
not accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Hereditary gastrointestinal polyposis syndromes

Luigi Ricciardiello

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Hereditary gastrointestinal polyposis syndromes are rare diseases that confer a significant risk of colorectal and other cancers. Correct diagnosis is needed to ensure patients undergo appropriate screening and follow-up for cancer prevention, and to ascertain risk in family members. Multidisciplinary management is essential to ensure appropriate clinical choices are made, and the involvement of a clinical geneticist is mandatory.

This online course addresses the various types of hereditary gastrointestinal polyposis syndrome. The genetic basis of each syndrome is considered, along with their presentation, extracolonic features, cancer risk, diagnosis, screening, surveillance and treatment options.

Learning objectives

 

  • To become familiar with hereditary gastrointestinal polyposis syndromes
  • To correctly diagnose hereditary gastrointestinal polyposis syndromes
  • To appropriately manage hereditary gastrointestinal polyposis syndromes

Target audience

This course is suitable for gastroenterologists in training and physicians and surgeons in other disciplines, as well as nurses, biotechnicians and advanced-years’ medical students who have an interest in gastroenterology. 

Event

Hereditary gastrointestinal polyposis syndromes

Topics

Digestive Oncology

Accreditation status

not accredited

Duration

1 hour

Published

2018

More Like This:

Intestinal failure and parenteral nutrition

Intestinal failure and parenteral nutrition

Sarah Williams Sarah Williams, Shameer Mehta

Proctology — haemorrhoids and perianal skin conditions

Proctology — haemorrhoids and perianal skin conditions

Nuha Yassin Nuha Yassin, Janindra Warusavitarne, Harald Rosen

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Acute pancreatitis

Acute pancreatitis

Markus M. Lerch Markus M. Lerch, Ali Alexander Aghdassi

Hereditary gastrointestinal polyposis syndromes

Hereditary gastrointestinal polyposis syndromes

Luigi Ricciardiello Luigi Ricciardiello

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

Boglarka Balogh Boglarka Balogh, Nora Sipeki, Peter Antal-Szalmas, Mária Papp, Jonel Trebicka, Tamás Tornai, Zsuzsanna Vitális, István Tornai, Lukacs Barath, Gabor Mehes, Tamas Dinya, Andras Kiss, Andras Budai, Aniko Csillag, David Tornai

UEG Poster
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

David Tornai 1, Boglarka Balogh 1, Aniko Csillag 1, Andras Budai 2, Andras Kiss 2, Tamas Dinya 1, Gabor Mehes 1, Lukacs Barath 1, István Tornai 1, Zsuzsanna Vitális 1, Nora Sipeki 1, Tamás Tornai 3, Peter Antal-Szalmas 1, Jonel Trebicka 4,5, Mária Papp 1

Affiliations

1 University of Debrecen, Faculty of Medicine, Debrecen, Hungary

2 Semmelweis University, Faculty of Medicine, Budapest, Hungary

3 Semmelweis University, Budapest, Hungary

4 University of Münster, Münster, Germany

5 European Foundation for Study of Chronic Liver Failure, Barcelona, Spain

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Dysfunctional and leaky gut barrier are characteristics of cirrhosis and associated with disease progression and mortality. Utility of biomarkers, indicating the presence and extent of intestinal barrier dysfunction, remains a controversial issue in the prognosis and risk stratification of decompensated cirrhosis. Villin-1 (VIL1) is an actin-bundling protein, present in the intestinal, renal and biliary brush border. VIL1 is downregulated in response to chronic injury and diverse cellular stressors, including the microbiome, while during acute stress it is redistributed from the brush border to the basolateral membrane, which facilitates its release into the blood.

Aims & Methods

We investigated clinical significance of serum VIL1 levels in patients with cirrhosis and acute decompensation (AD).Patients (n = 86) and healthy controls (HC; n = 50) from the MICROB-PREDICT cohort were tested for serum VIL1 by ELISA. Four patient severity sub-groups were defined according to the PREDICT study (stable AD (SDC), unstable AD (UDC), pre-ACLF and ACLF [acute-on-chronic liver failure]). VIL1 immunohistochemistry (IHC) evaluation of duodenum biopsy was performed in a sub-cohort of the patients (n = 13) and controls (n = 11).

Results

Serum VIL1 levels were decreased in SDC patients (median [IQR]: 6.5 [4.9-10.4] vs 12 [8.4-14.9] ng/mL, p < 0.001) compared to controls and increased in more severe disease. This difference was confirmed in duodenum tissue by IHC. Significantly higher serum VIL1 levels were detected in pre-ACLF patients compared to those who did not develop ACLF (10.7 [7.8-22.9] vs 6.9 [5.0-10.5] ng/mL, p = 0.004), while in ACLF survivors decreased VIL1 levels were observed on day-7 compared to day-0 (9.8 [7.3-14.6] vs 12.7 [9.7-18.1] ng/mL, p = 0.010). High serum VIL1 levels (≥16.17 ng/mL) predicted 90-day mortality (AUROC:0.73, 95%CI: 0.563-0.888, p = 0.013) and in combination with high (≥ 50) CLIF-C AD score the prediction accuracy was excellent (both is high: 75%; all other together: 8% mortality, LogRank p < 0.001). High serum VIL1 level was able to predict mortality both in the presence (20% vs 62% LogRank p = 0.030) and absence (14% vs 40% LogRank p = 0.008) of renal failure.

Conclusion

Besides the six organ failures included in CLIF-SOFA, patients with cirrhosis and AD may also develop intestinal failure, as an additional organ failure. Serum VIL1 level could reliably indicate this organ failure and made the mortality risk stratification performed by CLIF-C OF score more accurate.

Disclosure

The MICROB-PREDICT project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825694

Conference

UEG Week Copenhagen 2023

Topics

Hepatobiliary

Submission format

Abstract

Session

Liver and biliary: Clinical aspects (Posters)

Citation

United European Gastroenterology Journal 2023; 11 (Supplement 8)

Published

2023

More Like This:

Intestinal failure and parenteral nutrition

Intestinal failure and parenteral nutrition

Sarah Williams Sarah Williams, Shameer Mehta

Proctology — haemorrhoids and perianal skin conditions

Proctology — haemorrhoids and perianal skin conditions

Nuha Yassin Nuha Yassin, Janindra Warusavitarne, Harald Rosen

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Acute pancreatitis

Acute pancreatitis

Markus M. Lerch Markus M. Lerch, Ali Alexander Aghdassi

Hereditary gastrointestinal polyposis syndromes

Hereditary gastrointestinal polyposis syndromes

Luigi Ricciardiello Luigi Ricciardiello

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

Boglarka Balogh Boglarka Balogh, Nora Sipeki, Peter Antal-Szalmas, Mária Papp, Jonel Trebicka, Tamás Tornai, Zsuzsanna Vitális, István Tornai, Lukacs Barath, Gabor Mehes, Tamas Dinya, Andras Kiss, Andras Budai, Aniko Csillag, David Tornai

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.